Skip to main content
NIH funding notice RFA-CA-23-028

Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)

Closed on September 30, 2024.

Posted
March 23, 2023
Close date
September 30, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,041,878 in first-year total cost, median $333,940.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 SRB-P (J1)]6

Most frequent institutions

  1. COLD SPRING HARBOR LABORATORY1
  2. UNIVERSITY OF CALIFORNIA-IRVINE1
  3. UNIVERSITY OF HAWAII AT HILO1
  4. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
  5. UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR1
Competing awards under RFA-CA-23-028 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer1UG3CA290364-01A1MOSES, JOHN EDWARDTUVESON, DAVID ACOLD SPRING HARBOR LABORATORY, NY$398,398ZCA1
2025Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma1UG3CA299397-01KRESTY, LAURA AUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$323,226ZCA1
2024Developing ribosome biogenesis inhibitors for the prevention of cancer1UG3CA290312-01BUSZCZAK, MICHAELTAGLIABRACCI, VINCENT SCOTTUT SOUTHWESTERN MEDICAL CENTER, TX$348,500ZCA1
2024Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors1UG3CA290375-01CAO, SHUGENGCHEN, XINWU, XUUNIVERSITY OF HAWAII AT HILO, HI$334,254ZCA1
2024Nautral products for targeting Skp2 in cancer interception1UG3CA290368-01ZI, XIAOLINUNIVERSITY OF CALIFORNIA-IRVINE, CA$333,625ZCA1
2024Discovery and Development of Natural Products for Interception of CRC1UG3CA290310-01RAO, CHINTHALAPALLY V.UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK$303,875ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-23-028: Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) | ScienceDex | ConductScience